Insider Transactions in Q1 2024 at Abb Vie Inc. (ABBV)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2024
|
Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER |
SELL
Open market or private sale
|
Direct |
21,082
-27.38%
|
$3,710,432
$176.3 P/Share
|
|
Mar 18
2024
|
Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
58,949
-19.5%
|
$10,492,922
$178.86 P/Share
|
|
Mar 18
2024
|
Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
26,110
+17.88%
|
$1,592,710
$61.36 P/Share
|
|
Mar 01
2024
|
Timothy J. Richmond EVP, CHIEF HR OFFICER |
SELL
Open market or private sale
|
Direct |
75,680
-34.96%
|
$13,395,360
$177.04 P/Share
|
|
Mar 01
2024
|
Timothy J. Richmond EVP, CHIEF HR OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
45,700
+33.8%
|
$2,787,700
$61.36 P/Share
|
|
Feb 29
2024
|
Perry C Siatis EVP, GC AND SECRETARY |
SELL
Open market or private sale
|
Direct |
9,891
-28.32%
|
$1,750,707
$177.54 P/Share
|
|
Feb 29
2024
|
Robert A. Michael PRES & CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
68,879
-22.64%
|
$12,122,704
$176.45 P/Share
|
|
Feb 29
2024
|
Robert A. Michael PRES & CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,560
+6.24%
|
$1,250,480
$58.11 P/Share
|
|
Feb 29
2024
|
Kevin K Buckbee SVP, CONTROLLER |
SELL
Open market or private sale
|
Direct |
5,144
-42.42%
|
$905,344
$176.65 P/Share
|
|
Feb 28
2024
|
Richard A Gonzalez EXECUTIVE CHAIRMAN OF BOARD |
SELL
Open market or private sale
|
Direct |
138,616
-21.08%
|
$24,535,032
$177.27 P/Share
|
|
Feb 28
2024
|
Richard A Gonzalez EXECUTIVE CHAIRMAN OF BOARD |
SELL
Payment of exercise price or tax liability
|
Direct |
110,249
-14.36%
|
$19,624,322
$178.99 P/Share
|
|
Feb 28
2024
|
Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
16,771
-17.89%
|
$2,985,238
$178.99 P/Share
|
|
Feb 28
2024
|
Roopal Thakkar SVP, CMO, GLOBAL THERAPEUTICS |
SELL
Payment of exercise price or tax liability
|
Direct |
4,914
-17.44%
|
$874,692
$178.99 P/Share
|
|
Feb 28
2024
|
Thomas J Hudson SVP, CSO, GLOBAL RESEARCH |
SELL
Payment of exercise price or tax liability
|
Direct |
20,634
-16.13%
|
$3,672,852
$178.99 P/Share
|
|
Feb 28
2024
|
Timothy J. Richmond EVP, CHIEF HR OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
23,847
-35.24%
|
$4,244,766
$178.99 P/Share
|
|
Feb 28
2024
|
Azita Saleki Gerhardt EVP, CHIEF OPERATIONS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
23,966
-9.82%
|
$4,265,948
$178.99 P/Share
|
|
Feb 28
2024
|
Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
26,121
-21.79%
|
$4,649,538
$178.99 P/Share
|
|
Feb 28
2024
|
Perry C Siatis EVP, GC AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
7,885
-27.99%
|
$1,403,530
$178.99 P/Share
|
|
Feb 28
2024
|
Robert A. Michael PRES & CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
37,638
-20.5%
|
$6,699,564
$178.99 P/Share
|
|
Feb 28
2024
|
Kevin K Buckbee SVP, CONTROLLER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,339
-27.79%
|
$950,342
$178.99 P/Share
|
|
Feb 28
2024
|
Scott T Reents EVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
11,634
-42.99%
|
$2,070,852
$178.99 P/Share
|
|
Feb 27
2024
|
Richard A Gonzalez EXECUTIVE CHAIRMAN OF BOARD |
SELL
Bona fide gift
|
Direct |
4,195
-0.27%
|
-
|
|
Feb 23
2024
|
Scott T Reents EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,140
-34.32%
|
$2,502,780
$177.44 P/Share
|
|
Feb 23
2024
|
Scott T Reents EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,140
+25.55%
|
$862,540
$61.36 P/Share
|
|
Feb 23
2024
|
Perry C Siatis EVP, GC AND SECRETARY |
SELL
Open market or private sale
|
Direct |
13,753
-32.8%
|
$2,434,281
$177.51 P/Share
|
|
Feb 23
2024
|
Perry C Siatis EVP, GC AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
13,753
+10.89%
|
$1,829,149
$133.36 P/Share
|
|
Feb 21
2024
|
Azita Saleki Gerhardt EVP, CHIEF OPERATIONS OFFICER |
SELL
Open market or private sale
|
Direct |
52,870
-17.81%
|
$9,146,510
$173.71 P/Share
|
|
Feb 21
2024
|
Azita Saleki Gerhardt EVP, CHIEF OPERATIONS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
52,870
+15.12%
|
$3,066,460
$58.88 P/Share
|
|
Feb 15
2024
|
Timothy J. Richmond EVP, CHIEF HR OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
53,827
+18.31%
|
-
|
|
Feb 15
2024
|
Azita Saleki Gerhardt EVP, CHIEF OPERATIONS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
54,095
+5.41%
|
-
|
|
Feb 15
2024
|
Richard A Gonzalez EXECUTIVE CHAIRMAN OF BOARD |
BUY
Grant, award, or other acquisition
|
Direct |
248,865
+7.8%
|
-
|
|
Feb 15
2024
|
Robert A. Michael PRES & CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
84,957
+11.09%
|
-
|
|
Feb 15
2024
|
Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
58,960
+11.92%
|
-
|
|
Feb 15
2024
|
Thomas J Hudson SVP, CSO, GLOBAL RESEARCH |
BUY
Grant, award, or other acquisition
|
Direct |
46,572
+8.69%
|
-
|
|
Feb 15
2024
|
Scott T Reents EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,256
+25.36%
|
-
|
|
Feb 15
2024
|
Perry C Siatis EVP, GC AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
17,796
+16.11%
|
-
|
|
Feb 15
2024
|
Roopal Thakkar SVP, CMO, GLOBAL THERAPEUTICS |
BUY
Grant, award, or other acquisition
|
Direct |
17,796
+16.11%
|
-
|
|
Feb 15
2024
|
Kevin K Buckbee SVP, CONTROLLER |
BUY
Grant, award, or other acquisition
|
Direct |
12,048
+14.78%
|
-
|
|
Feb 15
2024
|
Nicholas Donoghoe EVP, CHIEF BUS/STRAT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,853
+9.65%
|
-
|
|
Feb 02
2024
|
Perry C Siatis EVP, GC AND SECRETARY |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,919
-21.95%
|
$496,230
$170.0 P/Share
|
|
Feb 02
2024
|
Perry C Siatis EVP, GC AND SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
2,919
+18.0%
|
$420,336
$144.54 P/Share
|